Jun 07, 2023 / 01:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. Good morning. Thanks, everybody, for joining us and being here. I'm Brandon Couillard from the Life Science Tools and Diagnostics team. Welcome to the Jefferies 2023 New York Global Healthcare conference. Very happy to have Agilent with us at the conference today. Joining us, CEO, as most of you probably know, Mike McMullen; as well as CFO, Bob McMahon. Thanks, everybody, for being here.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
I think we agreed to share the mic. Hey, Brandon. So it's a pleasure to be here right on the heels of our recent Q2 earnings announcement. So pleasure to be here as always. Well, I think Bob is happy to be here as well.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystMaybe to jump into things on the topic dejour. That we've been having a lot of investor conversations about and we certainly are thinking -- coming out of
Trustpilot
